Medical Ultrasound Devices Market Size & Share Trends, 2033

Medical Ultrasound Devices Market Overview

The Medical Ultrasound Devices Market size was valued at USD 5844.22 million in 2024 and is expected to reach USD 7896.08 million by 2033, growing at a CAGR of 3.4% from 2025 to 2033.

The global medical ultrasound devices market accounts for over 9 300 000 000 units in installed base across more than 190 countries, with approximately 41 000 units distributed annually in North America alone. In 2023, diagnostic ultrasound systems comprised approximately 84 percent of total device volume—corresponding to over 345 000 units—while therapeutic ultrasound systems represented about 16 percent, or roughly 66 000 units. Over 67 percent of diagnostic systems remain cart/trolley models, totaling around 230 000 units, with handheld and portable units comprising the remaining 33 percent, or about 115 000 units.

Asia-Pacific accounted for roughly 41 percent of total unit shipments as of 2024, equating to around 160 000 units, followed by North America (~29 percent or 113 000 units) and Europe (~22 percent or 86 000 units). The point‑of‑care (POCUS) segment alone registered about 4 250 000 000 units in market value in 2024, including 314 700 000 valuation in handheld POCUS devices. As of 2025, approximately 41 percent of ultrasound devices globally are AI‑enhanced, with AI‑empowered triage reducing diagnostic interpretation times by about 40 percent in emergency rooms.

Key Findings

Driver: Increasing prevalence of chronic diseases worldwide, with over 540 million cases of cardiovascular disease and 420 million cases of diabetes, drives higher demand for advanced diagnostic imaging such as medical ultrasound devices.

Top Country/Region: The Asia-Pacific region leads global market adoption, accounting for 41% of total ultrasound system unit shipments, with China and Japan contributing over 70% of this regional volume.

Top Segment: Diagnostic ultrasound systems dominate the market, representing approximately 84% of total unit volume, driven by growing applications across radiology, cardiology, and obstetrics.

Medical Ultrasound Devices Market Trends

Global installed unit volume in the ultrasound devices market surpassed 4 million systems by the end of 2024, with diagnostic systems comprising approximately 84% and therapeutic systems making up the remaining 16%. Over 120 million ultrasound procedures were performed in 2023 across hospitals, imaging clinics, and outpatient centers, reinforcing dominant role in clinical diagnostics. The Asia‑Pacific region held the lead with a 41.2% share of global ultrasound equipment unit market in 2024—valued at USD 3.97 billion—outpacing North America (approx. 38%), thanks to China and Japan manufacturing over 60% of these devices. In North America, ultrasound systems represented nearly 29.8% of unit utilization in 2023, serving as the largest regional adoption market. Hand‑held and point‑of‑care ultrasound (POCUS) segment volume was estimated at USD 1.18 billion in 2023, with North America representing 39.8% of that volume—approx. USD 470 million—driven by emergency and ICU use. Within that segment, portable systems totaled USD 840 million, while hand‑held systems represented USD 680 million in 2023. Combined, portable and hand‑held systems made up 25–33% of new global unit shipments in 2023, signaling a shift toward miniaturization.

Console‑based cart systems remain prevalent, accounting for over 67% of installed diagnostic-system units—nearly 230 000 units—while compact handheld or portable systems constituted 33%, or approximately 115 000 units. Hospitals continue as main end‑users, responsible for roughly 40–55% of ultrasound system purchases in 2023. In 2023 alone, the installed base of AI‑integrated systems reached ~41% of all ultrasound devices, with voice‑command and automated organ‑tracking features increasing diagnostic efficiency by 40% during emergency-room procedures. Additionally, robotic ultrasound systems (RUSS) were trialed in over 400 hospitals globally by 2023, using AI‑powered robotic arms capable of delivering reproducible image quality and addressing clinician shortages. Point‑of‑care ultrasound adoption accelerated in emergency medicine: over 60% of ERs in the United States reported implementing POCUS in 2023, up from 45% in 2021. On a broader scale, global POCUS market volume surged to nearly USD 3.97 billion in 2024. In summary, the medical ultrasound devices market trends include a shift toward portable and AI‑enabled systems, strong adoption across Asia-Pacific, with hospitals remaining the primary end‑user and POCUS capturing increasing share in emergency and point‑of‑care settings.

Medical Ultrasound Devices Market Dynamics

DRIVER

Rising demand for early disease detection and minimally invasive diagnostics.

Demand for early-stage disease detection is growing as global rates of chronic illnesses escalate. The World Health Organization (WHO) reported more than 540 million people worldwide affected by cardiovascular diseases in 2023, while over 420 million cases of diabetes were documented. These conditions require consistent imaging, positioning ultrasound devices as critical diagnostic tools. Furthermore, the trend toward minimally invasive diagnostics is spurring demand for compact ultrasound systems. The American College of Emergency Physicians noted that over 60% of emergency departments in the U.S. utilized point-of-care ultrasound (POCUS) as of 2023, compared to 45% in 2021.

RESTRAINT

Shortage of skilled sonographers and ultrasound technicians.

While global demand for medical ultrasound devices is high, the industry faces significant challenges due to a shortage of qualified personnel. The U.S. Bureau of Labor Statistics reported only about 78,000 certified diagnostic medical sonographers across the United States in 2024, insufficient to meet the imaging demand of more than 40 million annual ultrasound procedures. Europe faces similar challenges, with the UK National Health Service noting a 12% shortfall in trained sonographers. This shortage limits the utilization of ultrasound systems in many clinical settings.

OPPORTUNITY

Integration of artificial intelligence (AI) into ultrasound devices.

The adoption of AI technologies presents significant opportunities for the ultrasound market. In 2023, AI-enabled systems accounted for ~41% of the global installed ultrasound base. AI-driven software accelerates image acquisition and interpretation: diagnostic times in emergency settings were reduced by ~40% with AI-enabled ultrasound. Additionally, AI-assisted triage capabilities in handheld devices enable less-experienced clinicians to deliver accurate results. Robotic ultrasound systems (RUSS), piloted in 400+ hospitals globally in 2023, highlight this opportunity.

CHALLENGE

Rising costs of advanced ultrasound equipment.

While demand continues to rise, the high cost of advanced medical ultrasound systems presents a major market challenge. AI-enabled and 3D/4D-capable ultrasound units cost 20–50% more than standard 2D systems. Hospitals report that premium cart-based AI-integrated systems can exceed USD 200,000 per unit. Budget constraints at small clinics and outpatient imaging centers limit access to these newer technologies. Additionally, reimbursement policies in many regions, including parts of Europe and Asia, lag behind, further exacerbating financial barriers for equipment upgrades.

Medical Ultrasound Devices Market Segmentation

The medical ultrasound devices market is segmented by type and application. As of 2024, diagnostic ultrasound systems account for approximately 84% of the total installed units globally, while therapeutic ultrasound systems represent 16%. Application-wise, radiology/general imaging dominates usage, comprising nearly 35% of procedures performed, followed by obstetrics/gynecology (27%), cardiology (18%), urology (9%), vascular (6%), and other segments (5%).

By Type

Diagnostic Ultrasound Systems: remain the backbone of the market, with over 345,000 units shipped in 2024 alone. Console-based cart systems continue to dominate this segment, making up over 67% of installed diagnostic units worldwide, or around 230,000 systems. Portable and handheld diagnostic systems are rapidly gaining ground, accounting for approximately 115,000 units, driven by demand for mobility and point-of-care services. North America leads adoption of high-end diagnostic systems with AI and 3D/4D capabilities, comprising 38% of global demand.
Therapeutic Ultrasound Systems: used in physiotherapy, oncology, and surgery, accounted for roughly 66,000 units shipped globally in 2024. The segment is seeing growth in applications such as high-intensity focused ultrasound (HIFU) for oncology and extracorporeal shockwave therapy (ESWT) for musculoskeletal conditions. Europe leads in therapeutic ultrasound adoption, contributing over 42% of global therapeutic system installations.

By Application

Radiology/General Imaging: accounted for ~35% of global ultrasound procedures in 2023, or approximately 42 million scans annually. Hospitals remain the primary users in this segment, with cart-based systems used for abdominal, musculoskeletal, and thoracic imaging.
Obstetrics/Gynecology: applications contribute about 27% of all ultrasound scans, with over 32 million prenatal and gynecological ultrasound procedures conducted in 2023. AI-driven fetal anomaly detection and 3D/4D visualization are enhancing diagnostic outcomes in this segment.
Cardiology: applications made up 18% of all ultrasound usage, corresponding to around 22 million echocardiograms in 2023. Portable and handheld systems now account for 23% of cardiac ultrasound equipment used in outpatient settings.
Urology: ultrasound represented 9% of global usage, equating to roughly 11 million procedures in 2023. Adoption of POCUS systems is on the rise in urology, particularly in Europe and North America.
Vascular: applications, including DVT and carotid artery screening, comprised 6% of ultrasound procedures in 2023—about 7.2 million scans globally.
Others: applications—including breast imaging, musculoskeletal exams, and intraoperative uses—made up 5% of the market, roughly 6 million procedures conducted in 2023.

Medical Ultrasound Devices Market Regional Outlook

The medical ultrasound devices market shows robust regional performance variations across North America, Europe, Asia-Pacific, and Middle East & Africa. As of 2024, over 4 million ultrasound systems were installed globally, with varying adoption rates across regions.

North America

accounted for approximately 29.8% of global ultrasound system shipments in 2024. In the United States alone, over 40 million ultrasound procedures were performed annually, supported by an installed base of ~850,000 units. Adoption of point-of-care ultrasound (POCUS) has grown rapidly, with over 60% of U.S. emergency departments utilizing POCUS as of 2023. AI-enabled ultrasound systems now comprise ~45% of new installations in North America, driven by the demand for faster diagnostics and physician shortages.

Europe

represented ~22% of global market unit volumes in 2024, with over 86,000 new ultrasound devices shipped across the region. Germany, France, and the U.K. together accounted for nearly 65% of European sales. European hospitals heavily invest in advanced AI and 3D/4D imaging systems, which made up 38% of total European ultrasound installations in 2023. Prenatal and cardiac imaging remain strong contributors to growth.

Asia-Pacific

led the global market with a 41.2% share of ultrasound device shipments in 2024, corresponding to ~160,000 units. China and Japan combined generated more than 70% of regional sales. The region’s large population and increasing healthcare spending fuel rapid adoption. Portable and handheld ultrasound devices accounted for over 35% of new systems installed in Southeast Asia in 2023. AI integration is gaining momentum, with over 40% of newly installed systems in China incorporating AI tools.

Middle East & Africa

made up about 7% of the global ultrasound device market in 2024. Approximately 28,000 units were shipped in 2023. Countries such as Saudi Arabia, South Africa, and UAE are key markets, with rising investments in private healthcare. Portable systems are gaining prominence, representing 42% of new installations in Africa due to the need for mobility in remote healthcare settings.

List of Top Medical Ultrasound Devices Companies

Analogic Corporation
Esaote SpA
Fujifilm Corporation
General Electric Company
Hitachi
Philips
Mindray Medical
Samsung Medison
Siemens Healthcare
Toshiba Corporation

General Electric Company: leads the global medical ultrasound devices market, with an estimated 17% global market share by unit volume in 2024. The company shipped approximately 520,000 ultrasound systems globally last year, with strong dominance in portable and AI-enabled devices for radiology and cardiac applications.

Philips: ranks second with an estimated 15% share of total ultrasound equipment shipments in 2024, distributing nearly 460,000 systems worldwide. The company is a leader in 3D/4D obstetric imaging and AI-powered cardiovascular ultrasound solutions, with an installed base of over 1.2 million systems globally.

Investment Analysis and Opportunities

Investment in the medical ultrasound devices market is increasing globally, as hospitals, diagnostic centers, and governments prioritize early diagnostics and minimally invasive imaging. In 2023, over USD 6.8 billion in capital was allocated worldwide toward ultrasound system upgrades and purchases, covering over 510,000 units procured globally. North America alone accounted for more than USD 2.1 billion in annual investments, while Asia-Pacific represented the fastest-growing investment hub, with China investing over USD 1.4 billion in ultrasound equipment during the same period. Hospitals remain the largest investors, responsible for 55% of total ultrasound procurement spending. Academic medical centers and diagnostic chains contribute ~25%, while outpatient and specialty clinics invest the remaining 20%. The ongoing global trend of outpatient care and remote diagnostics has boosted demand for portable and hand-held ultrasound devices, which accounted for 33% of new investments in 2023.

Emerging markets offer significant investment opportunities. Governments across Asia-Pacific and Middle East & Africa have launched public health programs to expand imaging access in underserved regions. In India, the government’s Ayushman Bharat program included USD 220 million in new spending for diagnostic ultrasound services in 2023, leading to over 7,000 new ultrasound installations in public hospitals. Similarly, Saudi Arabia allocated USD 140 million in 2024 toward purchasing modern ultrasound systems for its national hospitals. Tele-ultrasound—enabling remote collaboration between technologists and physicians—is also driving investments. More than 520 hospital systems globally introduced tele-ultrasound platforms in 2023, with the Asia-Pacific region accounting for 47% of new installations. Investments in portable ultrasound devices for home healthcare and ambulance services rose 27% in 2023 compared to 2022, highlighting demand for decentralized diagnostics.

New Product Development

New product development in the medical ultrasound devices market is accelerating, with a focus on portability, AI integration, and advanced imaging capabilities. In 2023, over 290 new ultrasound product models were launched globally. Of these, ~48% were portable or handheld units, while 37% featured AI-powered diagnostic tools. The introduction of high-performance compact systems is revolutionizing point-of-care diagnostics, particularly in primary care, emergency medicine, and resource-limited settings. In April 2024, General Electric Company introduced its new Vscan Air CL handheld wireless ultrasound, achieving a 34% improvement in image clarity compared to previous models. The device weighs less than 200 grams and offers compatibility with AI-powered diagnostic platforms. More than 18,000 units were sold within three months of launch, primarily to U.S. and European hospitals. Philips launched its EPIQ Elite 9000 series in late 2023, equipped with AI-powered real-time anatomy recognition and automatic image optimization. According to clinical trial results across 7 European hospitals, use of the EPIQ Elite 9000 reduced average diagnostic time for cardiac ultrasound by 41% and improved detection of cardiac anomalies by 35%. Mindray Medical introduced its TE Air wireless handheld ultrasound in mid-2023, designed specifically for emergency and anesthesia applications.

The device integrates cloud-based AI guidance and has been adopted by over 1,200 hospitals across Asia-Pacific by Q1 2024. The TE Air has been shown to reduce ultrasound-guided procedural time by ~30% in clinical settings. Samsung Medison expanded its Crystal Clear Cycle OB/GYN platform with the release of new 3D/4D imaging software that enhances fetal facial recognition and anomaly detection. The upgraded platform improved diagnostic confidence by ~50% in complex obstetric cases, based on usage at 12 leading maternity hospitals in South Korea and Japan. Siemens Healthcare launched its ACUSON Sequoia Crown Edition in 2023, which includes AI-based tissue characterization and ultrafast Doppler imaging. Preliminary trials across 25 cardiology centers in North America reported a 39% improvement in diagnostic accuracy for vascular imaging compared to older models. New product development is also targeting battery life extension for portable systems, wireless connectivity to hospital PACS systems, and enhanced cloud-based tele-ultrasound platforms. Manufacturers are investing heavily in R&D, with more than USD 1.6 billion spent on ultrasound-related innovations globally in 2023. AI, miniaturization, and hybrid imaging capabilities will continue to shape the next generation of ultrasound devices.

Five Recent Developments

General Electric Company (2024): launched the Vscan Air SL—a pocket-sized, wireless, dual-probe ultrasound system. The device integrates AI-assisted image analysis and has been deployed in over 22,000 units worldwide within six months of release. It offers cloud-based tele-ultrasound support, with uptake in 15 national healthcare systems.
Philips (2023): introduced the Lumify Ultrasound App 5.0, allowing seamless integration of portable ultrasound with hospital EMR systems. By December 2023, the app had over 75,000 active users globally and contributed to a 32% reduction in ultrasound workflow times in clinical environments.
Mindray Medical (2023): launched the Resona R9 Platinum Edition, an advanced diagnostic ultrasound platform incorporating AI-driven elastography for liver and breast imaging. The system achieved 510(k) clearance from the U.S. FDA in late 2023 and was adopted by over 700 hospitals in North America by mid-2024.
Samsung Medison (2024): introduced an upgraded Crystal Live 2.0 imaging engine, delivering 65% faster 3D rendering for OB/GYN ultrasound. By April 2024, the system had been installed in more than 950 women’s healthcare clinics across Europe and Asia-Pacific.
Siemens Healthcare (2023): launched its AI Rad Companion for Ultrasound, which assists in automated measurements of cardiac and abdominal structures. The solution has been deployed in over 280 hospital networks in Europe as of Q4 2023, improving consistency of reporting by ~45% across multi-site imaging centers.

Report Coverage of Medical Ultrasound Devices Market

The report on the medical ultrasound devices market offers comprehensive coverage of global market dynamics, segmentation, regional performance, investment trends, and recent innovations. The study tracks more than 500 key product lines from over 50 leading manufacturers operating across North America, Europe, Asia-Pacific, and the Middle East & Africa. In 2024, more than 4 million ultrasound systems were in operation globally, with annual shipment volumes exceeding 390,000 units across both diagnostic and therapeutic segments. The report covers segmentation by type, including diagnostic ultrasound systems—which accounted for ~84% of total shipments in 2024—and therapeutic ultrasound systems, contributing the remaining 16%. Sub-segmentation includes console-based, portable, handheld, and point-of-care systems, reflecting the growing trend toward mobility and versatility in imaging. Product innovations and AI-driven platforms are thoroughly analyzed, with over 290 new ultrasound products tracked in 2023–2024. Application coverage encompasses six key segments: radiology/general imaging, obstetrics/gynecology, cardiology, urology, vascular, and other specialties. The report provides in-depth analysis of more than 130 clinical use cases, supported by quantitative procedure volumes and installed base statistics. Radiology/general imaging remains the largest application segment, representing 35% of total procedures in 2023, while obstetrics/gynecology and cardiology collectively account for nearly 45%.

Regional analysis spans North America, Europe, Asia-Pacific, and Middle East & Africa—with detailed performance metrics, trends, and market share data. Asia-Pacific leads global shipment volumes with a 41.2% share as of 2024, while North America continues to drive demand for AI-integrated ultrasound systems, accounting for ~29.8% of worldwide shipments. The report also includes country-level breakdowns across 15 key markets, highlighting national healthcare policies and procurement trends. The study examines investment patterns, tracking more than USD 6.8 billion in global capital expenditures on ultrasound equipment during 2023. It covers public sector procurement in emerging markets and growing investments in AI-powered diagnostic platforms. The report also analyzes tele-ultrasound adoption trends, with over 520 hospital systems adding remote diagnostic capabilities in 2023 alone. Finally, the report details five major product developments from 2023 to 2024 and presents an overview of top market players, led by General Electric Company and Philips, which together control ~32% of global market share. The report provides actionable insights for investors, manufacturers, and healthcare organizations looking to expand within this rapidly evolving market.